Last Updated:
Name Designation Appointment Date Status
Kandoth Kunnumpreth Vinupal

Appointed as Director since November 2017

Director 27-Nov-2017 Current
Premium access

Complete director details

Unlock the complete director and KMP records available for Solistaa Pharmaceuticals Private Limited.

  • Complete appointment and designation records
  • Current and past company associations
  • Shareholding and remuneration where filed

Verified entity values are shown only after access is granted.

Paramasivan Sivarajakumar

Appointed as Director since November 2017

Director 27-Nov-2017 Current
Sundararajalu

Appointed as Director since January 2018

Director 30-Jan-2018 Current

People Timeline

Explore the timeline of key personnel in Solistaa Pharmaceuticals Private Limited's leadership journey.

Loading...
Contact Details
  • Address No.37, 1St Cross, Perumal Raja Garden Reddiarpalayam, Pondicherry Pondicherry, 605010, India
  • Telephone Upgrade
  • Email Upgrade
  • Pin Code 605010
  • Country India
  • Website solistaa.in
  • Social Media
Frequently Asked Questions
You can contact Solistaa Pharmaceuticals Private Limited through their registered address at No.37, 1St Cross, Perumal Raja Garden Reddiarpalayam, Pondicherry Pondicherry, 605010, India, or via their website at solistaa.in. Social media links are also provided where applicable.
The current directors of Solistaa Pharmaceuticals Private Limited are listed above in the "Current Directors & Signatories" section. You can view their names, designations, and appointment dates.
  • PARAMASIVAN SIVARAJAKUMAR
  • KANDOTH KUNNUMPRETH VINUPAL
  • SUNDARARAJALU
Past director details are available under the "Past Directors & Signatories" tab. You may need to upgrade your subscription to view detailed information.
Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available